Proteomics and irritable bowel syndrome (Q39232397)

10 September 2017

title

Proteomics and irritable bowel syndrome (English)

1 reference

10 September 2017

author name string

Athanasios Tsigaridas

1 reference

10 September 2017

Ioannis S Papanikolaou

1 reference

10 September 2017

Anna Vaiopoulou

1 reference

10 September 2017

Athanasios K Anagnostopoulos

1 reference

10 September 2017

Nikos Viazis

1 reference

10 September 2017

George Karamanolis

1 reference

10 September 2017

Dimitrios G Karamanolis

1 reference

10 September 2017

George T Tsangaris

1 reference

10 September 2017

Gerasimos J Mantzaris

1 reference

10 September 2017

Maria Gazouli

1 reference

10 September 2017

language of work or name

1 reference

11 April 2017

1 reference

Expert Review of Proteomics

10 September 2017

published in

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

page(s)

461-468

1 reference

Comparison of the Rome IV and Rome III criteria for IBS diagnosis: A cross-sectional survey

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

New Pathways, New Targets: Visceral Hypersensitivity Pathogenesis in Irritable Bowel Syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Life course study of the etiology of self-reported irritable bowel syndrome in the 1958 British birth cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Post-infectious irritable bowel syndrome--a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Systematic review with meta-analysis: post-infectious irritable bowel syndrome after travellers' diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Overlapping gastroesophageal reflux disease and irritable bowel syndrome: increased dysfunctional symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Comorbidity in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Proteomic serum biomarkers and their potential application in cancer screening programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Diagnosis of IBS: symptoms, symptom-based criteria, biomarkers or 'psychomarkers'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Densities of rectal peptide YY and somatostatin cells as biomarkers for the diagnosis of irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Alternative investigations for irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Laboratory markers in IBD: useful, magic, or unnecessary toys?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Hydrogen sulphide in exhaled breath: a potential biomarker for small intestinal bacterial overgrowth in IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Colonic mucosal N-methyl-D-aspartate receptor mediated visceral hypersensitivity in a mouse model of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Brain-Derived Neurotrophic Factor Contributes to Colonic Hypermotility in a Chronic Stress Rat Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Exogenous interleukin-6 facilitated the contraction of the colon in a depression rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Pro-inflammatory chemokine C-C motif ligand 16 (CCL-16) dysregulation in irritable bowel syndrome (IBS): a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Mucosal cytokine imbalance in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Implications of functional proteomics in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Proteomics in nutrition and health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Searching for the noninvasive biomarker holy grail: are urine proteomics the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Correlation between protein and mRNA abundance in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Mass spectrometry-based proteomics turns quantitative

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Proteome analysis of Lactobacillus rhamnosus GG using 2-D DIGE and mass spectrometry shows differential protein production in laboratory and industrial-type growth media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

An investigation of fecal volatile organic metabolites in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Western blot: technique, theory, and trouble shooting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Breast cancer, version 3.2013: featured updates to the NCCN guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

When tissue antigens and antibodies get along: revisiting the technical aspects of immunohistochemistry--the red, brown, and blue technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Shugan-decoction relieves visceral hyperalgesia and reduces TRPV1 and SP colon expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Crosstalk between interleukin-6 and corticotropin-releasing factor modulate submucosal plexus activity and colonic secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Two-dimensional differential in-gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Advances in proteomic prostate cancer biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Urinary proteomics evaluation in interstitial cystitis/painful bladder syndrome: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Proteomic analysis of colonic mucosa in a rat model of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Protein arrays: proteomics in multiplex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

A proteome chip approach reveals new DNA damage recognition activities in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Global analysis of the glycoproteome in Saccharomyces cerevisiae reveals new roles for protein glycosylation in eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Overview of protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Antibody-based microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Protein microarrays: catching the proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Protein microarray technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Anti-enteric neuronal antibodies and the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Differentiating coeliac disease from irritable bowel syndrome by urinary volatile organic compound analysis--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

Gastrointestinal permeability in patients with irritable bowel syndrome assessed using a four probe permeability solution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2017.1317600

10.1080/14789450.2017.1317600

21 January 2018

Identifiers

DOI

1 reference

release_rsgkktrljzdsrirs3ctmnbpz3u

10 September 2017

Fatcat ID

0 references

1 reference